Dopamine cell transplantation in Parkinsons disease: Challenge and perspective

British Medical Bulletin

Volumn 100, Issue 1, 2011, Pages 173-189

  Ma, Yilong ^a   Peng, Shichun ^a   Dhawan, Vijay ^a   Eidelberg, David ^a  

^a FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

Author keywords

cell transplantation; emission tomography; Parkinsons disease; regenerative medicine

Indexed keywords

DOPAMINE; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR;

ARTICLE; CELL SURVIVAL; CELL TRANSPLANTATION; DYSKINESIA; FETUS CELL; HUMAN; NEURAL STEM CELL TRANSPLANTATION; NONHUMAN; PARKINSON DISEASE; PARKINSONISM; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

BRAIN; EMBRYONIC STEM CELLS; HUMANS; PARKINSON DISEASE; POSITRON-EMISSION TOMOGRAPHY; STEM CELL TRANSPLANTATION; SUBSTANTIA NIGRA; TREATMENT OUTCOME;

EID: 83255189653     PISSN: 00071420     EISSN: 14718391     Source Type: Journal    
DOI: 10.1093/bmb/ldr040     Document Type: Article

References (48)

1. Dauer W, Przedborski S. Parkinson's disease: mechanisms and models. Neuron 2003;39:889-909. (Pubitemid 37130207)
2. Freed CR, Greene PE, Breeze RE et al. Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N Engl J Med 2001;344:710-9. (Pubitemid 32204988)
3. Olanow CW, Goetz CG, Kordower JH et al. A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease. Ann Neurol 2003;54:403-14. (Pubitemid 37072046)
4. Lindvall O, Bjorklund A. Cell therapy in Parkinson's disease. NeuroRx 2004;1:382-93. (Pubitemid 46589366)
5. Ma Y, Dhawan V, Freed C et al. PET and embryonic dopamine cell transplantation in Parkinson's disease. In: Broderick PA, Rabni DN, Kolodny EH (eds). Bioimaging in Neurodegeneration. New Jersey: Humana Press, 2005,45-58.
6. Cochen V, Ribeiro MJ, Nguyen JP et al. Transplantation in Parkinson's disease: PET changes correlate with the amount of grafted tissue. Mov Disord 2003;18:928-32. (Pubitemid 37021169)
7. Piccini P, Pavese N, Hagell P et al. Factors affecting the clinical outcome after neural transplantation in Parkinson's disease. Brain 2005;128:2977-86. (Pubitemid 41746650)
8. Ma Y, Peng S, Flores J et al. Abnormal metabolic brain network in parkinsonian macaques: modulation by retinal pigment epithelial (RPE) cell implantation. Neurology 2008;71:154-55.
9. Vinuela A, Hallett PJ, Reske-Nielsen C et al. Implanted reuptake-deficient or wild-type dopaminergic neurons improve ON L-dopa dyskinesias without OFF-dyskinesias in a rat model of Parkinson's disease. Brain 2008;131:3361-79.
10. Soderstrom KE, Meredith G, Freeman TB et al. The synaptic impact of the host immune response in a parkinsonian allograft rat model: influence on graft-derived aberrant behaviors. Neurobiol Dis 2008;32:229-42.
11. Trott CT, Fahn S, Greene P et al. Cognition following bilateral implants of embryonic dopamine neurons in PD: a double blind study. Neurology 2003;60:1938-43. (Pubitemid 36736009)
12. McRae C, Cherin E, Diem G et al. Does personality change as a result of fetal tissue transplantation in the brain. J Neurol 2003;250:282-6. (Pubitemid 36399266)
13. Nakamura T, Dhawan V, Chaly T et al. Blinded positron emission tomography study of dopamine cell implantation for Parkinson's disease. Ann Neurol 2001;50:181-7. (Pubitemid 32738142)
14. Ma Y, Tang C, Chaly T et al. Dopamine cell implantation in Parkinson's disease: long-term clinical and (18)F-FDOPA PET outcomes. J Nucl Med 2010;51:7-15.
15. Brundin P, Pogarell O, Hagell P et al. Bilateral caudate and putamen grafts of embryonic mesencephalic tissue treated with lazaroids in Parkinson's disease. Brain 2000;123(Pt 7):1380-90. (Pubitemid 30420938)
16. Kordower JH, Chu Y, Hauser RA et al. Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease. Nat Med 2008;14:504-6. (Pubitemid 351655212)
17. Li JY, Englund E, Holton JL et al. Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation. Nat Med 2008;14:501-3. (Pubitemid 351655211)
18. Mendez I, Vinuela A, Astradsson A et al. Dopamine neurons implanted into people with Parkinson's disease survive without pathology for 14 years. Nat Med 2008;14:507-9. (Pubitemid 351655215)
19. Piccini P, Brooks DJ, Bjorklund A et al. Dopamine release from nigral transplants visualized in vivo in a Parkinson's patient. Nat Neurosci 1999;2:1137-40. (Pubitemid 30126374)
20. Politis M, Wu K, Loane C et al. Serotonergic neurons mediate dyskinesia side effects in Parkinson's patients with neural transplants. Sci Transl Med 2010;2:38-46.
21. Ma Y, Feigin A, Dhawan V et al. Dyskinesia after fetal cell transplantation for parkinsonism: a PET study. Ann Neurol 2002;52:628-34. (Pubitemid 35246867)
22. Carlsson T, Winkler C, Lundblad M et al. Graft placement and uneven pattern of reinnervation in the striatum is important for development of graft-induced dyskinesia. Neurobiol Dis 2006;21:657-68. (Pubitemid 43277547)
23. Lane EL, Winkler C, Brundin P et al. The impact of graft size on the development of dyskinesia following intrastriatal grafting of embryonic dopamine neurons in the rat. Neurobiol Dis 2006;22:334-45.
24. Maries E, Kordower JH, Chu Y et al. Focal not widespread grafts induce novel dyskinetic behavior in parkinsonian rats. Neurobiol Dis 2006;21:165-80. (Pubitemid 41817316)
25. Lane EL, Soulet D, Vercammen L et al. Neuroinflammation in the generation of posttransplantation dyskinesia in Parkinson's disease. Neurobiol Dis 2008;32:220-8.
26. Hagell P, Piccini P, Bjorklund A et al. Dyskinesias following neural transplantation in Parkinson's disease. Nat Neurosci 2002;5:627-8. (Pubitemid 34742975)
27. Lane EL, Vercammen L, Cenci MA et al. Priming for L-DOPA-induced abnormal involuntary movements increases the severity of amphetamine-induced dyskinesia in grafted rats. Exp Neurol 2009;219:355-8.
28. Lane EL, Brundin P, Cenci MA. Amphetamine-induced abnormal movements occur independently of both transplant-and host-derived serotonin innervation following neural grafting in a rat model of Parkinson's disease. Neurobiol Dis 2009;35:42-51.
29. Allan LE, Petit GH, Brundin P. Cell transplantation in Parkinson's disease: problems and perspectives. Curr Opin Neurol 2010;23:426-32.
30. Kim HJ. Stem cell potential in Parkinson's disease and molecular factors for the generation of dopamine neurons. Biochim Biophys Acta 2011;1812:1-11.
31. Doudet DJ, Cornfeldt ML, Honey CR et al. PET imaging of implanted human retinal pigment epithelial cells in the MPTP-induced primate model of Parkinson's disease. Exp Neurol 2004;189:361-8. (Pubitemid 39221828)
32. Eidelberg D. Metabolic brain networks in neurodegenerative disorders: a functional imaging approach. Trends Neurosci 2009;32:548-57.
33. Stover NP, Bakay RA, Subramanian T et al. Intrastriatal implantation of human retinal pigment epithelial cells attached to microcarriers in advanced Parkinson disease. Arch Neurol 2005;62:1833-7. (Pubitemid 41785076)
34. Gage FH. Mammalian neural stem cells. Science 2000;287:1433-8. (Pubitemid 30127128)
35. Takagi Y, Takahashi J, Saiki H et al. Dopaminergic neurons generated from monkey embryonic stem cells function in a Parkinson primate model. J Clin Invest 2005;115:102-9. (Pubitemid 40385510)
36. Redmond DE Jr, Bjugstad KB, Teng YD et al. Behavioral improvement in a primate Parkinson's model is associated with multiple homeostatic effects of human neural stem cells. Proc Natl Acad Sci USA 2007;104:12175-80. (Pubitemid 47185649)
37. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006;126:663-76. (Pubitemid 44233629)
38. Wernig M, Zhao JP, Pruszak J et al. Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease. Proc Natl Acad Sci USA 2008;105:5856-61. (Pubitemid 351758462)
39. Hargus G, Cooper O, Deleidi M et al. Differentiated Parkinson patient-derived induced pluripotent stem cells grow in the adult rodent brain and reduce motor asymmetry in Parkinsonian rats. Proc Natl Acad Sci USA 2010;107:15921-6.
40. Lévesque M, Neuman T, Rezak M. Therapeutic microinjection of autologous adult human neural stem cells and differentiated neurons for Parkinson's disease: five-year post-operative outcome. Open Stem Cell J 2009;1:20-29.
41. Mendez I, Dagher A, Hong M et al. Enhancement of survival of stored dopaminergic cells and promotion of graft survival by exposure of human fetal nigral tissue to glial cell linederived neurotrophic factor in patients with Parkinson's disease. Report of two cases and technical considerations. J Neurosurg 2000;92:863-9. (Pubitemid 30243937)
42. Patel NK, Bunnage M, Plaha P et al. Intraputamenal infusion of glial cell line-derived neurotrophic factor in PD: a two-year outcome study. Ann Neurol 2005;57:298-302. (Pubitemid 40179870)
43. Lang AE, Gill S, Patel NK et al. Randomized controlled trial of intraputamenal glial cell linederived neurotrophic factor infusion in Parkinson disease. Ann Neurol 2006;59:459-66. (Pubitemid 43358066)
44. Kells AP, Eberling J, Su X et al. Regeneration of the MPTP-lesioned dopaminergic system after convection-enhanced delivery of AAV2-GDNF. J Neurosci 2010;30:9567-77.
45. Hedlund E, Pruszak J, Lardaro T et al. Embryonic stem cell-derived Pitx3-enhanced green fluorescent protein midbrain dopamine neurons survive enrichment by fluorescence-activated cell sorting and function in an animal model of Parkinson's disease. Stem Cells 2008;26:1526-36.
46. Mendez I, Sanchez-Pernaute R, Cooper O et al. Cell type analysis of functional fetal dopamine cell suspension transplants in the striatum and substantia nigra of patients with Parkinson's disease. Brain 2005;128:1498-510. (Pubitemid 41373670)
47. Grealish S, Jonsson ME, Li M et al. The A9 dopamine neuron component in grafts of ventral mesencephalon is an important determinant for recovery of motor function in a rat model of Parkinson's disease. Brain 2010;133:482-95.
48. Mendez I, Dagher A, Hong M et al. Simultaneous intrastriatal and intranigral fetal dopaminergic grafts in patients with Parkinson disease: a pilot study. Report of three cases. J Neurosurg 2002;96:589-96. (Pubitemid 34230217)